Investors Sue MedMen for Alleged Breach of Fiduciary Duty

One of MedMen’s Largest Outside Shareholders and Former Board Member, an Affiliate of The Inception Companies, Sues MedMen and Alleges Breach of Fiduciary Duty

LOS ANGELES, January 08, 2019–(BUSINESS WIRE)–This morning in the Superior Court of Los Angeles, California, The Inception Companies founders Brent Cox and Omar Mangalji (through an affiliated entity – MMMG-MC, Inc. – that holds a significant stake in MedMen’s management company MMMG, LLC) filed a complaint against Adam Bierman, Andrew Modlin and various MedMen Enterprises entities for alleged breaches of fiduciary duty.

Cox stated, “We have a long history with MedMen – as one of the largest and original shareholders of the company. Sadly, we are backed into a corner here and compelled to take action on behalf of all stakeholders of the company.” Cox is a former board member of MedMen, serving in that role from March 2016 to March 2018 and Founder of The Inception Companies.

Simply put, MedMen is a publicly traded company that is withholding its shares from its shareholders. Management is using conflicted corporate structuring in breach of its fiduciary duty to its shareholders.

Omar Mangalji, Partner and Founder of The Inception Companies

He continued to say, “MedMen touts itself as a torchbearer of best practices and even claims in their advertising campaigns that they are ‘Mainstreaming Marijuana.’ If that is the case then they need to adopt mainstream corporate governance practices. This industry is exciting and rife with opportunity, but unless we engender a safe and accountable environment for individuals and institutions to invest their capital, the explosive growth will be stifled. Given the industry’s storied history and its varied stages of legality in different markets, it is doubly important that our industry be well above board in all of its corporate practices.”

A full copy of the complaint can be read here:

About The Inception Companies

The Inception Companies (“Inception”) is a private opportunistic investment firm based in Los Angeles and London with significant operating and investing experience across numerous industries, including regulated cannabis. Inception and its affiliates have deployed capital in leading consumer retail brands, agricultural & industrial operations, technology platforms, and real estate assets representing over $2 billion in aggregate enterprise value. Inception’s principals have over 60 years of combined investing and operating experience at prominent investment banking, private equity, real estate, and venture capital firms. For additional information, visit

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter